Trump DOJ Reschedules Cannabis - But Only for Some, Leaving Industry in Limbo
The U.S. Justice Department moved cannabis to Schedule 3 of the Controlled Substances Act - but drew a sharp line that the industry did not expect. Only FDA-approved drug products containing